missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30167723

KIR2DL4/CD158d Antibody (181703) [Janelia Fluor™ 669], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB2238JF669

Product Code. 30167723

  • £657.00 / 0.50mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

KIR2DL4/CD158d Monoclonal antibody specifically detects KIR2DL4/CD158d in Human samples. It is validated for Flow Cytometry,Agonist Activity,CyTOF-reported
TRUSTED_SUSTAINABILITY
Specifications

Specifications

KIR2DL4/CD158d
Monoclonal
Janelia Fluor 669
103AS, 15.212, CD158 antigen-like family member D, CD158d antigen, CD158DKIR103ASKiller cell inhibitory receptor 103AS, G9P, killer cell immunoglobulin-like receptor 2DL4, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, killer Ig receptor, KIR103, KIR-103AS, MHC class I NK cell receptor KIR103AS, natural killer cell inhibitory receptor, NK cell receptor
BaF3 mouse pro-B cell line transfected with human KIR2DL4/CD158d, Accession # Q99706
0.5 mL
Immunology
3805
Store at 4°C in the dark.
IgG2a
Flow Cytometry, Agonist Activity, CyTOF
181703
50mM Sodium Borate
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.